Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 160

1.

Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials.

Eikelboom JW, Quinlan DJ, O'Donnell M.

Circulation. 2009 Nov 17;120(20):2006-11. doi: 10.1161/CIRCULATIONAHA.109.872630. Epub 2009 Nov 2.

PMID:
19884469
[PubMed - indexed for MEDLINE]
Free Article
2.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
[PubMed - indexed for MEDLINE]
3.

Prevention of venous thromboembolism in hospitalized acutely ill medical patients: focus on the clinical utility of (low-dose) fondaparinux.

Di Nisio M, Porreca E.

Drug Des Devel Ther. 2013 Sep 16;7:973-80. doi: 10.2147/DDDT.S38042. eCollection 2013. Review.

PMID:
24068866
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

The safety of fondaparinux for the prevention and treatment of venous thromboembolism.

Turpie AG.

Expert Opin Drug Saf. 2005 Jul;4(4):707-21. Review.

PMID:
16011449
[PubMed - indexed for MEDLINE]
5.

Improvements in the prevention of postoperative venous thromboembolism in hip fracture patients.

Eriksson BI.

Orthopedics. 2003 Aug;26(8 Suppl):s851-8. Review.

PMID:
12934740
[PubMed - indexed for MEDLINE]
6.

Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.

Nijkeuter M, Huisman MV.

Curr Opin Pulm Med. 2004 Sep;10(5):338-44. Review.

PMID:
15316429
[PubMed - indexed for MEDLINE]
7.

Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy.

Turpie AG.

Expert Opin Pharmacother. 2004 Jun;5(6):1373-84. Review.

PMID:
15163281
[PubMed - indexed for MEDLINE]
8.

Venous thromboembolism and prophylaxis in cancer patients.

Paskauskas S, Pundzius J, Barauskas G.

Medicina (Kaunas). 2008;44(3):175-81. Review.

PMID:
18413983
[PubMed - indexed for MEDLINE]
Free Article
9.

Fondaparinux in the management of patients with ST-elevation acute myocardial infarction.

Turpie AG.

Vasc Health Risk Manag. 2006;2(4):371-8. Review.

PMID:
17323591
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prevention of venous thromboembolism in hospitalized medical patients: addressing some practical questions.

Douketis JD.

Curr Opin Pulm Med. 2008 Sep;14(5):381-8. doi: 10.1097/MCP.0b013e3283043dcf. Review.

PMID:
18664966
[PubMed - indexed for MEDLINE]
11.

[Perioperative venous thromboembolism prophylaxis: short review and recommendations].

Samama CM.

Ann Fr Anesth Reanim. 2008 Dec;27 Suppl 3:S2-8. doi: 10.1016/S0750-7658(08)75140-2. Review. French.

PMID:
19185783
[PubMed - indexed for MEDLINE]
12.

Extended thromboprophylaxis with low-molecular-weight heparins after hospital discharge in high-risk surgical and medical patients: a review.

Huo MH, Muntz J.

Clin Ther. 2009 Jun;31(6):1129-41. doi: 10.1016/j.clinthera.2009.06.002. Review.

PMID:
19695383
[PubMed - indexed for MEDLINE]
13.

Major bleeding rates after prophylaxis against venous thromboembolism: systematic review, meta-analysis, and cost implications.

Muntz J, Scott DA, Lloyd A, Egger M.

Int J Technol Assess Health Care. 2004 Fall;20(4):405-14. Review.

PMID:
15609788
[PubMed - indexed for MEDLINE]
14.

Prevention of venous thromboembolism in the hospitalized medical patient.

Jaffer AK, Amin AN, Brotman DJ, Deitelzweig SB, McKean SC, Spyropoulos AC.

Cleve Clin J Med. 2008 Apr;75 Suppl 3:S7-16. Review.

PMID:
18494223
[PubMed - indexed for MEDLINE]
Free Article
15.

Challenges in the prevention of venous thromboembolism in the elderly.

Di Minno G, Tufano A.

J Thromb Haemost. 2004 Aug;2(8):1292-8. Review.

PMID:
15304033
[PubMed - indexed for MEDLINE]
16.

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review.

Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Sch√ľnemann HJ.

J Exp Clin Cancer Res. 2008 Jul 18;27:21. doi: 10.1186/1756-9966-27-21. Review.

PMID:
18634550
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Fondaparinux sodium: a review of its use in the management of acute coronary syndromes.

Blick SK, Orman JS, Wagstaff AJ, Scott LJ.

Am J Cardiovasc Drugs. 2008;8(2):113-25. Review. Erratum in: Am J Cardiovasc Drugs. 2008;8(6):427.

PMID:
18422394
[PubMed - indexed for MEDLINE]
18.

Primary prophylaxis of venous thromboembolism in surgical patients.

Rawat A, Huynh TT, Peden EK, Kougias P, Lin PH.

Vasc Endovascular Surg. 2008 Jun-Jul;42(3):205-16. doi: 10.1177/1538574408315208. Epub 2008 Mar 28. Review.

PMID:
18375602
[PubMed - indexed for MEDLINE]
19.

Low-molecular-weight heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review.

Ribic C, Lim W, Cook D, Crowther M.

J Crit Care. 2009 Jun;24(2):197-205. doi: 10.1016/j.jcrc.2008.11.002. Epub 2009 Feb 7. Review.

PMID:
19327323
[PubMed - indexed for MEDLINE]
20.

Venous thromboembolism prophylaxis for the medical patient: where do we stand?

Yavin Y, Cohen AT.

Semin Respir Crit Care Med. 2008 Feb;29(1):75-82. doi: 10.1055/s-2008-1047565. Review.

PMID:
18302089
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk